XML 47 R38.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT INFORMATION

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

 

   For the Three Months Ended March 31, 
   2022   2021 
Net revenues:          
Reportable segments:          
Regenerative medicine products  $   $1,729 
Contract services   741    2,980 
Total net revenues  $741   $4,709 
           
Net income/(loss):          
Reportable segments:          
Regenerative medicine products  $(3,545)  $(17,702)
Contract services   (226)   292 
Total net loss  $(3,771)  $(17,410)